Detalles de la búsqueda
1.
Ceritinib in ALK-rearranged non-small-cell lung cancer.
N Engl J Med
; 370(13): 1189-97, 2014 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24670165
2.
Changes in dural sac caliber with standing MRI improve correlation with symptoms of lumbar spinal stenosis.
Eur Spine J
; 26(10): 2666-2675, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28702785
3.
Liquid chromatography tandem mass spectrometry method for the quantitative analysis of ceritinib in human plasma and its application to pharmacokinetic studies.
Anal Bioanal Chem
; 406(28): 7389-96, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25258279
4.
A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor.
Clin Cancer Res
; 29(18): 3659-3667, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37363962
5.
Erratum to: Changes in dural sac caliber with standing MRI improve correlation with symptoms of lumbar spinal stenosis.
Eur Spine J
; 26(10): 2676-2677, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28776130
6.
Development of an individualized procedure to induce reward-related impulsivity and evaluating its impact on drinking control.
Addict Behav
; 133: 107378, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644056
7.
Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK + advanced tumors.
Cancer Chemother Pharmacol
; 87(4): 475-486, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33394101
8.
Phase 1/2 study of ceritinib in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non-small cell lung cancer previously treated with crizotinib: Results from ASCEND-6.
Lung Cancer
; 150: 240-246, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33249379
9.
Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non-Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study.
J Thorac Oncol
; 15(3): 392-403, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31634667
10.
Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Am J Physiol Endocrinol Metab
; 297(5): E1105-14, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19706786
11.
Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys.
J Pharmacol Exp Ther
; 329(1): 102-11, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19129372
12.
Intraosseous glomus tumor treated by toe-to-finger transfer: case report.
J Hand Surg Am
; 34(4): 710-4, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19345875
13.
Application of time-dependent modeling for the exposure-efficacy analysis of ceritinib in untreated ALK-rearranged advanced NSCLC patients.
Cancer Chemother Pharmacol
; 84(3): 501-511, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31020351
14.
Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)-Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study.
J Thorac Oncol
; 14(7): 1255-1265, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30851442
15.
Evaluation of a simplified therapeutic intervention scoring system (TISS-28) and the modified early warning score (MEWS) in predicting physiological deterioration during inter-facility transport.
Resuscitation
; 76(1): 47-51, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17728045
16.
Population Pharmacokinetics of Ceritinib in Adult Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase.
J Clin Pharmacol
; 57(5): 652-662, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27922734
17.
Assessment of drug-drug interaction potential between ceritinib and proton pump inhibitors in healthy subjects and in patients with ALK-positive non-small cell lung cancer.
Cancer Chemother Pharmacol
; 79(6): 1119-1128, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28424965
18.
ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC).
J Thorac Oncol
; 12(9): 1357-1367, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28729021
19.
Triaging referral to a specialist breast clinic.
ANZ J Surg
; 76(5): 310-2, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16768688
20.
Predation by Red Foxes (Vulpes vulpes) at an Outdoor Piggery.
Animals (Basel)
; 6(10)2016 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27740601